Clinical Trial Update: Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating treatment response using CHOI and RECIST criteria and CT texture analysis in metastatic colorectal cancer patients trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED